Vinergy Capital Inc. has executed a non-binding Letter of Intent ("LOI") to acquire an interest in a healthcare AI Platform ("AIP") company based in California with an additional option to gain exlusive rights to the AIP for healthcare services. In conjunction with the LOI, the Company has appointed Michael Dalsin as Chairman of the Company's investment committee. The Company announced that Michael Dalsin, an investment expert with over 25 years experience specializing in healthcare products, technology and services, has been appointed to the investment committee of the Company and will act as Chair of the Investment Committee.

Mr. Dalsin was Executive Chairman of Patient Home Monitoring (PHM) and Convalo Health, both Canadian listed healthcare companies, as well as founder and Industry Advisor to The Healthcare Special Opportunity Fund, which is also a listed Canadian company. He has been asked to be a recurring guest lecturer at Yale University Medical School on the topic of fund flows and capital in the global healthcare economy.